We are live on ! Find out more
LCM

Laurion Capital Management Portfolio holdings

AUM $2.29B
1-Year Est. Return 75.73%
This Fund
S&P 500
This Quarter Est. Return
+22.45%
1 Year Est. Return
+75.73%
3 Year Est. Return
+162.63%
5 Year Est. Return
+130.38%
10 Year Est. Return
+388.8%
AUM
$12.9B
AUM Growth
+$4.54B
Cap. Flow
+$2.5B
Cap. Flow %
19.33%
Top 10 Hldgs %
36.19%
Holding
1,073
New
278
Increased
122
Reduced
146
Closed
468

Top Sells

Rank Stock Value
1
C icon
Citigroup
C
+$87.5M
2
GLD icon
SPDR Gold Trust
GLD
+$79.7M
3
XOM icon
ExxonMobil
XOM
+$68.3M
4
CVX icon
Chevron
CVX
+$56.1M
5
QQQ icon
Invesco QQQ Trust
QQQ
+$53.5M

Sector Composition

Rank Sector Weight
1 Healthcare 8.37%
2 Technology 2.34%
3 Industrials 2.33%
4 Consumer Discretionary 2.24%
5 Energy 1.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VST icon
301
Vistra
VST
$48.2B
$2.92M 0.02%
148,399
+9,414
+7% +$175K
RPRX icon
302
Royalty Pharma
RPRX
$25.8B
$2.9M 0.02%
58,000
+8,000
+16% +$339K
MU icon
303
Micron Technology
MU
$972B
$2.85M 0.02%
+37,900
New +$2.29M
ETSY icon
304
CALL
Etsy
ETSY
$7.38B
$2.81M 0.02%
+15,800
New +$2.38M
LESL icon
305
Leslie's
LESL
$10.4M
$2.77M 0.02%
+5,000
New +$2.25M
WFC icon
306
Wells Fargo
WFC
$265B
$2.77M 0.02%
91,723
-865,819
-90% -$22.4M
PRAX icon
307
Praxis Precision Medicines
PRAX
$10.2B
$2.75M 0.02%
+3,333
New +$1.95M
EW icon
308
PUT
Edwards Lifesciences
EW
$53B
$2.74M 0.02%
+30,000
New +$2.49M
GDRX icon
309
GoodRx Holdings
GDRX
$1.25B
$2.7M 0.02%
67,000
AMZN icon
310
Amazon
AMZN
$3T
$2.7M 0.02%
16,580
-298,180
-95% -$47.6M
RH icon
311
PUT
RH
RH
$3.47B
$2.69M 0.02%
+6,000
New +$2.47M
BLDR icon
312
Builders FirstSource
BLDR
$7.74B
$2.68M 0.02%
+65,615
New +$2.32M
CMBM
313
DELISTED
Cambium Networks
CMBM
$2.67M 0.02%
106,310
+3,435
+3% +$79.3K
PTGX icon
314
Protagonist Therapeutics
PTGX
$9.71B
$2.62M 0.02%
+130,158
New +$2.8M
NFE icon
315
New Fortress Energy
NFE
$97.8M
$2.61M 0.02%
+48,698
New +$2.23M
DMRA
316
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.82B
$2.59M 0.02%
+8,302
New +$3.09M
OPCH icon
317
Option Care Health
OPCH
$3.67B
$2.59M 0.02%
165,347
+34,927
+27% +$520K
PTC icon
318
PTC
PTC
$16.4B
$2.54M 0.02%
+21,234
New +$2.11M
AMWL icon
319
American Well
AMWL
$231M
$2.53M 0.02%
5,000
KDP icon
320
PUT
Keurig Dr Pepper
KDP
$39.9B
$2.48M 0.02%
+77,500
New +$2.29M
MHK icon
321
Mohawk Industries
MHK
$9.19B
$2.48M 0.02%
17,570
-142,430
-89% -$17.2M
TJX icon
322
TJX Companies
TJX
$175B
$2.45M 0.02%
35,855
-151,745
-81% -$9.23M
LEN.B icon
323
Lennar Class B
LEN.B
$20.2B
$2.45M 0.02%
42,088
GS icon
324
Goldman Sachs
GS
$301B
$2.44M 0.02%
9,250
+9,075
+5,186% +$2.02M
FDMT icon
325
4D Molecular Therapeutics
FDMT
$582M
$2.4M 0.02%
+58,000
New +$2.39M

Similar funds

Laurion Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Laurion Capital Management held 1,073 positions worth $12.9B, up 54% from $8.4B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Laurion Capital Management deployed $2.5B of net new capital in Q4 2020, opening 278 new positions and adding to 122 existing holdings. Its largest new stake was Viatris: 23,234,371 shares worth $435M.

By sector, the portfolio is most concentrated in Healthcare at 8.4% of assets, up from 4.5% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was ExxonMobil, an estimated $68.3M trimmed.

  • Laurion Capital Management's largest Q4 2020 buy was Viatris: 23,234,371 shares worth $435M.
  • Laurion Capital Management added most to Intel in Q4 2020, an estimated $89.9M increase.
  • Laurion Capital Management's biggest Q4 2020 reduction was ExxonMobil, cutting an estimated $68.3M.
  • Laurion Capital Management fully exited Citigroup in Q4 2020, selling an estimated $87.5M.
  • Laurion Capital Management's ten largest holdings make up 36% of its $12.9B portfolio in Q4 2020.
  • Laurion Capital Management opened 278 new positions and closed 468 in Q4 2020.
  • Laurion Capital Management's portfolio value rose 54% quarter-over-quarter to $12.9B.

Based on Laurion Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.